Breast cancer patient benefits from modified immunotherapy ¶
By: Jason E. Barkeloo on June 26, 2018, 6:35 p.m.
Breast cancer patient benefits from modified immunotherapy
Researchers designed a novel approach to immunotherapy that led to the complete regression of breast cancer in a patient for whom all other treatments failed.
Jason E. Barkeloo
Chairman & Founder, Open Therapeutics